About the Product

Description


Fluvoxyle 150 Tablet containing Fluvoxamine is used for the management of depressive disorders, obsessive-compulsive disorder, and anxiety-related conditions. It helps support emotional well-being and mental health under medical supervision.

Fluvoxamine works as a selective serotonin reuptake inhibitor (SSRI) that helps increase serotonin levels in the brain, supporting mood regulation and emotional balance.

The tablet is widely prescribed in psychiatric practice for depression, obsessive-compulsive disorder, and related anxiety disorders, leading to consistent prescription demand.

With increasing awareness of mental health and growing demand for effective psychiatric therapies, this product offers strong business potential for retailers and distributors. Its established clinical relevance, therapeutic value, and steady market demand make it a reliable product for growth in the neuro psychiatry segment.

Some patients may experience nausea, vomiting, headache, dizziness, insomnia, drowsiness, dry mouth, sweating, nervousness, or gastrointestinal discomfort. Rarely, serotonin syndrome, severe allergic reactions, abnormal bleeding, manic episodes, or suicidal thoughts may occur and require immediate medical attention.

Fluvoxyle 150 Tablet is indicated for obsessive-compulsive disorder (OCD), major depressive disorder, anxiety disorders, panic disorder, social anxiety disorder, and related psychiatric conditions as prescribed by a healthcare professional. It helps reduce symptoms of anxiety, depression, intrusive thoughts, and compulsive behaviors.

This medicine should be used strictly under medical supervision. Patients should be monitored for worsening depression, unusual behavioral changes, or suicidal thoughts, especially during the initial stages of treatment or dosage adjustments. Do not discontinue therapy abruptly without consulting a healthcare professional. Use cautiously in patients with liver disease, seizure disorders, bipolar disorder, or those taking other serotonergic medications.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Fluvoxamine 150mg Tablet in the PCD pharma franchise market?

Fluvoxamine 150mg Tablet has strong demand in the psychiatry, mental health, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuropsychiatric and mental healthcare portfolios.

Why should medical distributors include Fluvoxamine 150mg Tablet in their product range?

management under medical supervision. Fluvoxamine 150mg is a selective serotonin reuptake inhibitor (SSRI) antidepressant Commonly prescribed for obsessive-compulsive disorder (OCD), anxiety disorders, depression, social anxiety disorder, and related psychiatric conditions Helps regulate serotonin levels in the brain, supporting emotional and mental well-being Higher-strength formulation is suitable for patients requiring dose escalation as prescribed by healthcare professionals This strengthens a comprehensive CNS and psychiatric care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Fluvoxamine 150mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand in psychiatric practice, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the CNS segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.